Summary
Hybrid Imaging in the Catheterization Room
In the previously-completed ERC CoG, we have developed a patented c-arm scanner (called IXSI) which can accomplish real-time hybrid image guidance in dynamic environments such as the intervention and the catheterization room. Thus far, we have evaluated IXSI for oncological purposes. But more recently, we have identified a new potential application in the field of interventional cardiology, in which hybrid imaging may help for determining the culprit vessel during the interventional procedure or directly evaluating the outcome of a treatment. In this ERC Proof of Concept, we will explore whether the new proposed application of IXSI is worth pursuing further. We will perform four tasks: i) we will investigate for which groups of cardiology patients or treatments IXSI may provide the greatest benefit and assess their market share, ii) we will evaluate the performance of IXSI for cardiology by developing custom-made testing devices, iii) we will investigate whether IXSI can be made more cost-effective for cardiology by making hardware modifications, and iv) by combining the information from the previous activities, we will develop a business case of IXSI specifically for cardiac interventions. Should it be demonstrated that IXSI can aid cardiac interventions, then we expect that our developed technology will be much quicker implemented in the clinic seeing that the proposed application field is massive and the incentive for commercialization would be greater (close to 1 million PCI procedures are performed per year in the US alone).
In the previously-completed ERC CoG, we have developed a patented c-arm scanner (called IXSI) which can accomplish real-time hybrid image guidance in dynamic environments such as the intervention and the catheterization room. Thus far, we have evaluated IXSI for oncological purposes. But more recently, we have identified a new potential application in the field of interventional cardiology, in which hybrid imaging may help for determining the culprit vessel during the interventional procedure or directly evaluating the outcome of a treatment. In this ERC Proof of Concept, we will explore whether the new proposed application of IXSI is worth pursuing further. We will perform four tasks: i) we will investigate for which groups of cardiology patients or treatments IXSI may provide the greatest benefit and assess their market share, ii) we will evaluate the performance of IXSI for cardiology by developing custom-made testing devices, iii) we will investigate whether IXSI can be made more cost-effective for cardiology by making hardware modifications, and iv) by combining the information from the previous activities, we will develop a business case of IXSI specifically for cardiac interventions. Should it be demonstrated that IXSI can aid cardiac interventions, then we expect that our developed technology will be much quicker implemented in the clinic seeing that the proposed application field is massive and the incentive for commercialization would be greater (close to 1 million PCI procedures are performed per year in the US alone).
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/101113441 |
| Start date: | 01-04-2023 |
| End date: | 30-09-2024 |
| Total budget - Public funding: | - 150 000,00 Euro |
Cordis data
Original description
Hybrid Imaging in the Catheterization RoomIn the previously-completed ERC CoG, we have developed a patented c-arm scanner (called IXSI) which can accomplish real-time hybrid image guidance in dynamic environments such as the intervention and the catheterization room. Thus far, we have evaluated IXSI for oncological purposes. But more recently, we have identified a new potential application in the field of interventional cardiology, in which hybrid imaging may help for determining the culprit vessel during the interventional procedure or directly evaluating the outcome of a treatment. In this ERC Proof of Concept, we will explore whether the new proposed application of IXSI is worth pursuing further. We will perform four tasks: i) we will investigate for which groups of cardiology patients or treatments IXSI may provide the greatest benefit and assess their market share, ii) we will evaluate the performance of IXSI for cardiology by developing custom-made testing devices, iii) we will investigate whether IXSI can be made more cost-effective for cardiology by making hardware modifications, and iv) by combining the information from the previous activities, we will develop a business case of IXSI specifically for cardiac interventions. Should it be demonstrated that IXSI can aid cardiac interventions, then we expect that our developed technology will be much quicker implemented in the clinic seeing that the proposed application field is massive and the incentive for commercialization would be greater (close to 1 million PCI procedures are performed per year in the US alone).
Status
SIGNEDCall topic
ERC-2022-POC2Update Date
31-07-2023
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
